Detalhe da pesquisa
1.
Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner.
BMC Cancer
; 24(1): 203, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350880
2.
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.
Lancet Oncol
; 21(9): 1213-1223, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888453
3.
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial.
Cancer Immunol Immunother
; 69(3): 477-488, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980913
4.
A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice.
BMC Cancer
; 17(1): 684, 2017 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29037232
5.
Neoadjuvant anti-tumor vaccination prior to surgery enhances survival.
J Transl Med
; 12: 245, 2014 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25186961
6.
Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging.
Proc Natl Acad Sci U S A
; 108(45): 18396-9, 2011 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22025695
7.
The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.
Front Toxicol
; 6: 1373003, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38694815
8.
Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy.
Sci Data
; 11(1): 448, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702329
9.
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes.
Oncoimmunology
; 13(1): 2345859, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38686178
10.
Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma.
PLoS One
; 18(5): e0274364, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146029
11.
The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues.
Cancer Immunol Immunother
; 61(7): 1101-11, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22193989
12.
Programmed death ligand 2 in cancer-induced immune suppression.
Clin Dev Immunol
; 2012: 656340, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22611421
13.
Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action.
Front Oncol
; 12: 960317, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35965519
14.
Temporally restricted activation of IFNß signaling underlies response to immune checkpoint therapy in mice.
Nat Commun
; 13(1): 4895, 2022 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986006
15.
CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy.
Cell Rep
; 41(13): 111874, 2022 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577370
16.
PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective.
iScience
; 25(1): 103571, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34984327
17.
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used.
Cancer Immunol Immunother
; 60(2): 249-60, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21069321
18.
Dendritic cell immunotherapy: mapping the way.
Nat Med
; 10(5): 475-80, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15122249
19.
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery.
J Immunother Cancer
; 9(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34059522
20.
Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
Clin Cancer Res
; 15(7): 2531-40, 2009 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19318472